Sol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III Epsolay® Program for the Treatment of Papulopustular Rosacea

Rosacea is a chronic and recurrent inflammatory dermatological disorder of unknown etiology. The disease is common, especially in fair-skinned people of Celtic and northern European heritage.

Global Rosacea Treatment Market 2018-2022 - Key Vendors are Allergan, Bayer, Bausch Health, Nestle & Sol-Gel Technologies -

DUBLIN--(BUSINESS WIRE)--Sep 20, 2018--The "Global Rosacea Treatment Market 2018-2022" report has been added to's offering. The Global Rosacea Treatment Market to grow at a CAGR ...